References analysis of the Wikipedia article "Homocisteína" in the Galician version

doi.org

dx.doi.org

Martí-Carvajal AJ, Solà I, Lathyris D, Salanti G (2009). Martí-Carvajal, Arturo J, ed. "Homocysteine lowering interventions for preventing cardiovascular events". Cochrane Database Syst Rev (4): CD006612. PMID 19821378. doi:10.1002/14651858.CD006612.pub2.

Selhub, J. (1999). "Homocysteine metabolism". Annual Review of Nutrition 19: 217–246. PMID 10448523. doi:10.1146/annurev.nutr.19.1.217.

Sibrian-Vazquez M, Escobedo JO, Lim S, Samoei GK, Strongin RM (2010). "Homocystamides promote free-radical and oxidative damage to proteins". Proc. Natl. Acad. Sci. U.S.A. 107 (2): 551–4. PMC 2818928. PMID 20080717. doi:10.1073/pnas.0909737107.

Martí-Carvajal, AJ; Solà, I; Lathyris, D; Salanti, G (2009-10-07). "Homocysteine lowering interventions for preventing cardiovascular events.". Cochrane database of systematic reviews (Online) (4): CD006612. PMID 19821378. doi:10.1002/14651858.CD006612.pub2.

Ahmadieh, H; Arabi, A (2011 Oct). "Vitamins and bone health: beyond calcium and vitamin D.". Nutrition Reviews 69 (10): 584–98. PMID 21967159. doi:10.1111/j.1753-4887.2011.00372.x.

Coen DA Stehouwer, Coen van Guldener (2001). "Homocysteine-lowering treatment: an overview". Expert Opinion on Pharmacotherapy 2 (9): 1449–1460. PMID 11585023. doi:10.1517/14656566.2.9.1449.

Lonn, E; Yusuf, S; Arnold, MJ; Sheridan, P; Pogue, J; Micks, M; McQueen, MJ; Probstfield, J; Fodor, G (2006). "Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease" (PDF). N Engl J Med 354 (15): 1567–77. PMID 16531613. doi:10.1056/NEJMoa060900. Arquivado dende o orixinal (PDF) o 08 de xullo de 2009. Consultado o 15 de xuño de 2013.

Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nicholls K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ (2006). "Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial". J Am Coll Cardiol 47 (6): 1108–16. PMID 16545638. doi:10.1016/j.jacc.2005.10.064.

Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K (2006). "Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction" (PDF). N Engl J Med 354 (15): 1578–88. PMID 16531614. doi:10.1056/NEJMoa055227. Arquivado dende o orixinal (PDF) o 08 de xullo de 2009. Consultado o 15 de xuño de 2013.

"B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial". The Lancet Neurology 9 (9): 855–865. 2010. doi:10.1016/S1474-4422(10)70187-3.

Smach MA, Jacob N, Golmard JL; Smach MA, Jacob N, Golmard JL, Charfeddine B, Lammouchi T, Ben Othman L, Dridi H, Bennamou S, Limem K.; et al. (2011). "Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study.". European Neurology 65 (5): 270–8. PMID 21474939. doi:10.1159/000326301.

Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C; et al. (2010). "Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial". PLoS ONE 5 (9): e12244. PMC 2935890. PMID 20838622. doi:10.1371/journal.pone.0012244.

Dietrich-Muszalska A, Malinowska J, Olas B; et al. (2012). "The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients". Neurochem. Res. 37 (5): 1057–62. PMC 3321271. PMID 22270909. doi:10.1007/s11064-012-0707-3.

McLean RR; et al. (2004). "Homocysteine as a predictive factor for hip fracture in older persons". New England Journal of Medicine 350 (20): 2042–2049. PMID 15141042. doi:10.1056/NEJMoa032739.Free text after free registration Arquivado 09 de marzo de 2009 en Wayback Machine.

van Meurs JB; et al. (2004). "Homocysteine levels and the risk of osteoporotic fracture". New England Journal of Medicine 350 (20): 2033–2041. PMID 15141041. doi:10.1056/NEJMoa032546.Free text after free registration Arquivado 17 de xaneiro de 2010 en Wayback Machine.

Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005). "Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial". JAMA 293 (9): 1082–8. PMID 15741530. doi:10.1001/jama.293.9.1082.

nejm.org

content.nejm.org

nih.gov

ncbi.nlm.nih.gov

Selhub, J. (1999). "Homocysteine metabolism". Annual Review of Nutrition 19: 217–246. PMID 10448523. doi:10.1146/annurev.nutr.19.1.217.

Jardine, MJ; Kang, A; Zoungas, S; Navaneethan, SD; Ninomiya, T; Nigwekar, SU; Gallagher, MP; Cass, A; Strippoli, G; Perkovic, V (2012-06-13). "The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis.". BMJ (Clinical research ed.) 344: e3533. PMC 3374481. PMID 22695899.

Vizzardi, E; Bonadei, I; Zanini, G; Frattini, S; Fiorina, C; Raddino, R; Dei Cas, L (2009 Jan). "Homocysteine and heart failure: an overview.". Recent patents on cardiovascular drug discovery 4 (1): 15–21. PMID 19149701.

Ahmadieh, H; Arabi, A (2011 Oct). "Vitamins and bone health: beyond calcium and vitamin D.". Nutrition Reviews 69 (10): 584–98. PMID 21967159. doi:10.1111/j.1753-4887.2011.00372.x.

Miller JW, Nadeau MR, Smith D and Selhub J (1994). "Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats". American Journal of Clinical Nutrition 59 (5): 1033–1039. PMID 8172087.

Coen DA Stehouwer, Coen van Guldener (2001). "Homocysteine-lowering treatment: an overview". Expert Opinion on Pharmacotherapy 2 (9): 1449–1460. PMID 11585023. doi:10.1517/14656566.2.9.1449.

Bleich S, Bleich K, Kropp S; et al. (2001). "Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the 'French Paradox'?". Alcohol Alcohol. 36 (3): 189–92. PMID 11373253.

Bleich S, Carl M, Bayerlein K; et al. (2005). "Evidence of increased homocysteine levels in alcoholism: the Franconian alcoholism research studies (FARS)". Alcohol. Clin. Exp. Res. 29 (3): 334–6. PMID 15770107.

Moris, MS. (2003). "Homocysteine and Alzheimer's disease.". Lancet Neurology 2 (7): 425–8. PMID 12849121.

pubchem.ncbi.nlm.nih.gov

nytimes.com

Legal note: Metabolite Laboratories is defending a patent as of March 2006 that may cover the mere mention or consideration of the relationship of vitamin B₁₂ and homocysteine levels. Ver Crichton, Michael (19 de marzo de 2006). "This Essay Breaks the Law". The New York Times (The New York Times Company). Consultado o 2006-03-20.

web.archive.org

According to Professor Melinda M. Manore of Oregon State University's Department of Nutrition and Exercise Sciences,http://www.supplementschat.org/homocysteine-b-vitamins-and-heart-disease.html Arquivado 26 de xaneiro de 2013 en Wayback Machine.

"The Doctor's Doctor: Homocysteine". Arquivado dende o orixinal o 05 de decembro de 2008. Consultado o 15 de xuño de 2013.

Adëeva Nutritionals Canada > Optimal blood test values Arquivado 29 de maio de 2009 en Wayback Machine. Consultado o 9 de xullo de 2009

Homocisteína (Galician Wikipedia)

adeeva.com

archive.org

bbc.co.uk

news.bbc.co.uk

chemspider.com

doi.org

dx.doi.org

ebi.ac.uk